11 months ago
Ayurveda Startup Kapiva Raises $60M for Expansion
Kapiva, an Indian company that makes Ayurveda products, just got a big investment of $60 million.
This money will help them make better products, build more factories, and advertise more.
They also plan to grow their business in countries like the UK, US, and UAE.
Kapiva makes things like supplements and skincare items, and one of their top sellers is a supplement for diabetes.
This investment shows that people are getting more interested in natural health products, which is a growing market in India.
Other companies are also competing in this market, but Kapiva is looking to expand and do even better.
Kapiva, an Ayurveda startup, secured $60 million in Series D funding.
The funding round included both primary and secondary transactions.
Funds will be used for R&D, manufacturing, marketing, and international expansion.
Kapiva's revenue nearly doubled in FY24, while reducing losses.
The Indian market for Ayurvedic products is expected to grow significantly.
- Who
- Kapiva, an Ayurveda startup
- What
- Raised $60 million in a Series D funding round.
- Where
- Based in India, with international subsidiaries.
- When
- The funding was recently announced.
- Why
- To boost R&D, manufacturing, marketing, and international expansion.
Key facts
- Amount Raised
- $60 million (INR 532 Cr)
- Funding Round
- Series D
- Lead Investors
- 360 ONE Asset, Vertex Growth
- Primary Transaction
- $28 million capital infusion
- Secondary Transaction
- $32 million
- Existing Investors
- Vertex Ventures, 3one4 Capital
- Founded
- 2016
- FY24 Revenue
- INR 228.6 Cr
- FY24 Loss
- INR 48.2 Cr
Quotes
Kapiva cofounder Ameve Sharma
The cofounder of Kapiva
“The top 5 categories contribute to 96-97% of revenue, which comprises diabetes, then the gym supplement category, followed by energy supplements, heart and liver”
inc42.com
